Behavioural effects of intracerebral dopaminergic grafts after neonatal destruction of the mesencephalic dopaminergic system.
Abrous
N
N
INSERM-U 259, Bordeaux, France.
Choulli
K
K
Simon
H
H
Le Moal
M
M
Herman
J P
JP
D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology*; D016380:Brain Tissue Transplantation / Q000502:physiology*; D003342:Corpus Striatum / Q000187:drug effects / Q000503:physiopathology*; D004298:Dopamine / Q000502:physiology*; D004327:Drinking Behavior / Q000187:drug effects / Q000502:physiology; D016332:Fetal Tissue Transplantation / Q000502:physiology*; D006892:Hydroxydopamines; D008297:Male; D008636:Mesencephalon / Q000196:embryology / Q000637:transplantation*; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D016627:Oxidopamine; D051381:Rats; D013037:Spatial Behavior; D016042:Transplantation, Heterotopic / Q000502:physiology
D006892:Hydroxydopamines; D016627:Oxidopamine; D001058:Apomorphine; D004298:Dopamine